| Medications as social phenomena D Cohen, M McCubbin, J Collin, G Pérodeau Health: 5 (4), 441-469, 2001 | 262 | 2001 |
| Persistence and determinants of statin therapy among middle‐aged patients for primary and secondary prevention S Perreault, L Blais, D Lamarre, A Dragomir, D Berbiche, L Lalonde, ... British journal of clinical pharmacology 59 (5), 564-573, 2005 | 168 | 2005 |
| Persistence with treatment in newly treated middle-aged patients with essential hypertension. S Perreault, D Lamarre, L Blais, A Dragomir, D Berbiche, L Lalonde, ... The Annals of pharmacotherapy 39 (9), 1401-1408, 2005 | 150 | 2005 |
| Patients’ perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy S Peláez, AJ Lamontagne, J Collin, A Gauthier, RM Grad, L Blais, ... BMC pulmonary medicine 15, 1-11, 2015 | 101 | 2015 |
| Factors associated with psychotropic drug use among community-dwelling older persons: A review of empirical studies P Voyer, D Cohen, S Lauzon, J Collin BMC nursing 3, 1-13, 2004 | 86 | 2004 |
| Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease S Perreault, L Blais, A Dragomir, MH Bouchard, L Lalonde, C Laurier, ... European journal of clinical pharmacology 61, 667-674, 2005 | 84 | 2005 |
| On social plasticity: the transformative power of pharmaceuticals on health, nature and identity J Collin Sociology of Health & illness 38 (1), 73-89, 2016 | 81 | 2016 |
| Risk perception and reasons for noncompliance in pharmacovigilance: a qualitative study conducted in Canada V Nichols, I Thériault-Dubé, J Touzin, JF Delisle, D Lebel, JF Bussières, ... Drug safety 32, 579-590, 2009 | 80 | 2009 |
| Les multiples facettes de la médicalisation du social J Collin, AJ Suissa Nouvelles pratiques sociales 19 (2), 25-33, 2007 | 73 | 2007 |
| Prescribing psychotropic medication for elderly patients: some physicians' perspectives N Damestoy, J Collin, R Lalande Cmaj 161 (2), 143-145, 1999 | 73 | 1999 |
| Observance et fonctions symboliques du médicament J Collin Gérontologie et société 25103 (4), 141-159, 2002 | 64 | 2002 |
| Comparison of midwifery care to medical care in hospitals in the Quebec pilot projects study: clinical indicators W Fraser, M Hatem-Asmar, I Krauss, F Maillard, G Bréart, R Blais, J Collin, ... Canadian Journal of public health 91 (1), I5-I11, 2000 | 59 | 2000 |
| La construction d'une rationalité: les médecins et la prescription de psychotropes aux personnes âgées J Collin, N Damestoy, R Lalande Sciences sociales et santé 17 (2), 31-52, 1999 | 47 | 1999 |
| Unconventional indicators of drug dependence among elderly long-term users of benzodiazepines P Voyer, M McCubbin, D Cohen, S Lauzon, J Collin, C Boivin Issues in Mental Health Nursing 25 (6), 603-628, 2004 | 46 | 2004 |
| Cost-effectiveness of midwifery services vs. medical services in Quebec D Reinharz, R Blais, WD Fraser, AP Contandriopoulos, J Collin, ... Canadian Journal of Public Health 91, I12-I15, 2000 | 44 | 2000 |
| Le médicament au cœur de la socialité contemporaine: regards croisés sur un objet complexe J Collin PUQ, 2006 | 42 | 2006 |
| Relations de sens et relations de fonction: risque et médicament 1 J Collin Sociologie et sociétés 39 (1), 99-122, 2007 | 41 | 2007 |
| Médicament et vieillesse: trois cas de figure J Collin Anthropologie et sociétés 27 (2), 119-138, 2003 | 40 | 2003 |
| Community pharmacists’ interventions in asthma care: a descriptive study N René-Henri, Y Khamla, N Nadaira, C Ouellet, L Blais, L Lalonde, ... Annals of Pharmacotherapy 43 (1), 104-111, 2009 | 39 | 2009 |
| Prescription psychostimulant use among young adults: A narrative review of qualitative studies C Robitaille, J Collin Substance Use & Misuse 51 (3), 357-369, 2016 | 36 | 2016 |
